ASSURE PROGRAM Trademark

Trademark Overview


On Monday, November 24, 2014, a trademark application was filed for ASSURE PROGRAM with the United States Patent and Trademark Office. The USPTO has given the ASSURE PROGRAM trademark a serial number of 86463775. The federal status of this trademark filing is REGISTERED as of Tuesday, July 16, 2019. This trademark is owned by Otsuka America Pharmaceutical, Inc.. The ASSURE PROGRAM trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing financial information about reimbursement for medical expenses for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders; providing insurance information about medical benefit verification and prior authorization services for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders; providing insurance information about medical records coding, billing, and compliance for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders

Promoting awareness of patient support offerings for central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment; discharge planning support, namely, providing consumer information to patients about health care plan options, products and programs in the field of managed care and state and federal medical care programs for central nervous system diseases, disorders and treatment and for vasopressin receptor antagonist responsive diseases, disorders, and treatment

Providing patient support in the nature of information about the location of medical treatment facilities for central nervous system diseases and disorders and for vasopressin receptor antagonist responsive diseases and disorders; providing medical information to medical professionals in the field of treatment of central nervous system diseases and disorders and of vasopressin receptor antagonist responsive diseases and disorders; providing a website for medical professionals featuring medical information in the field of treatment of central nervous system diseases and disorders and of vasopressin receptor antagonist responsive diseases and disorders
assure program

General Information


Serial Number86463775
Word MarkASSURE PROGRAM
Filing DateMonday, November 24, 2014
Status700 - REGISTERED
Status DateTuesday, July 16, 2019
Registration Number5807078
Registration DateTuesday, July 16, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 31, 2017

Trademark Statements


Goods and ServicesProviding financial information about reimbursement for medical expenses for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders; providing insurance information about medical benefit verification and prior authorization services for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders; providing insurance information about medical records coding, billing, and compliance for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders
Goods and ServicesPromoting awareness of patient support offerings for central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment; discharge planning support, namely, providing consumer information to patients about health care plan options, products and programs in the field of managed care and state and federal medical care programs for central nervous system diseases, disorders and treatment and for vasopressin receptor antagonist responsive diseases, disorders, and treatment
Goods and ServicesProviding patient support in the nature of information about the location of medical treatment facilities for central nervous system diseases and disorders and for vasopressin receptor antagonist responsive diseases and disorders; providing medical information to medical professionals in the field of treatment of central nervous system diseases and disorders and of vasopressin receptor antagonist responsive diseases and disorders; providing a website for medical professionals featuring medical information in the field of treatment of central nervous system diseases and disorders and of vasopressin receptor antagonist responsive diseases and disorders
NOT AVAILABLE"PROGRAM"

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, December 3, 2014
Primary Code035
First Use Anywhere DateMonday, November 24, 2014
First Use In Commerce DateMonday, November 24, 2014

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, September 16, 2015
Primary Code036
First Use Anywhere DateMonday, November 24, 2014
First Use In Commerce DateMonday, November 24, 2014

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 3, 2014
Primary Code044
First Use Anywhere DateMonday, November 24, 2014
First Use In Commerce DateMonday, November 24, 2014

Trademark Owner History


Party NameOtsuka America Pharmaceutical, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Party NameOtsuka America Pharmaceutical, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Party NameOtsuka America Pharmaceutical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events


Event DateEvent Description
Wednesday, December 3, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 27, 2014NEW APPLICATION ENTERED
Thursday, March 12, 2015ASSIGNED TO EXAMINER
Thursday, March 19, 2015NON-FINAL ACTION WRITTEN
Wednesday, September 16, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 19, 2015NON-FINAL ACTION E-MAILED
Thursday, March 19, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 16, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 16, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 1, 2015SUSPENSION LETTER WRITTEN
Thursday, October 1, 2015LETTER OF SUSPENSION E-MAILED
Thursday, October 1, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, April 20, 2016ASSIGNED TO LIE
Wednesday, April 27, 2016SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, May 18, 2016NON-FINAL ACTION WRITTEN
Wednesday, May 18, 2016NON-FINAL ACTION E-MAILED
Wednesday, May 18, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 18, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 18, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, November 19, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, December 10, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, December 24, 2016ASSIGNED TO LIE
Wednesday, December 28, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 11, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 31, 2017PUBLISHED FOR OPPOSITION
Tuesday, January 31, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 27, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, September 27, 2017SOU EXTENSION 1 FILED
Wednesday, September 27, 2017SOU EXTENSION 1 GRANTED
Friday, September 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 8, 2017TEAS STATEMENT OF USE RECEIVED
Wednesday, November 8, 2017USE AMENDMENT FILED
Monday, November 20, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 27, 2017ITU OFFICE ACTION ISSUED FOR STATEMENT OF USE
Friday, December 1, 2017RESPONSE TO ITU OFFICE ACTION ENTERED
Friday, December 1, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 8, 2017STATEMENT OF USE PROCESSING COMPLETE
Friday, December 29, 2017NON-FINAL ACTION E-MAILED
Friday, December 29, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 29, 2017SU - NON-FINAL ACTION - WRITTEN
Tuesday, March 27, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, March 27, 2018SOU EXTENSION 2 FILED
Friday, June 29, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 6, 2018SOU EXTENSION 2 GRANTED
Saturday, July 7, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 17, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 17, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 7, 2018SU - FINAL REFUSAL - WRITTEN
Tuesday, August 7, 2018FINAL REFUSAL E-MAILED
Tuesday, August 7, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 6, 2019EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, February 6, 2019JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, February 6, 2019EX PARTE APPEAL-INSTITUTED
Thursday, February 7, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, February 12, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 27, 2019NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Tuesday, February 12, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 27, 2019SU - ACTION CONTINUING FINAL - WRITTEN
Wednesday, February 27, 2019ACTION DENYING REQ FOR RECON E-MAILED
Sunday, June 9, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 11, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, July 8, 2019ASSIGNED TO EXAMINER
Tuesday, July 16, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, July 16, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, May 17, 2019JURISDICTION RESTORED TO EXAMINING ATTORNEY